Shareholders

Shareholders in Chordate Medical Holding AB per 2020-12-31

Shareholder Number of shares Votes and capital %
Sifonen AB 8 584 613 7,9%
HAWOC Investment AB  8 125 000 7,5%
Isak Brandberg AB med närstående  8 076 427 7,4%
 Nordnet Pensionsförsäkring AB 6 606 608 6,1%
 Midroc Invest AB  6 160 250 5,7%
 Tommy Hedberg  5 854 167 5,4%
 Henrik Rammer  5 369 798 4,9%
Bevaclean AB 4 875 000 4,5%
 Tiven GmbH  4 759 798 4,4%
Försäkringsaktiebolaget Avanza Pension  2 969 552 2,7%
Other shareholders 47 424 619 43,6%
Total 108 805 832 100,0%

We are a Swedish medical technology company listed on NGM Nordic SME.

Chordate has spent more than 10 years developing the Kinetic Oscillation Stimulation, K.O.S, a technique for treating rhinitis and migraine. We have a patent on K.O.S in the EU and the United States, as well as many other countries.

We have answered frequently asked questions in our FAQ. If you want to know more, please get in touch.

IR contact